ABSTRACT
Shave excision is a simple and cost-effective technique for the removal of suitable skin lesions. We performed a prospective study over six months, collecting data from pigmented lesions that were treated with shave excision by dermatologists. Only shave excisions with the intent to remove the lesion in toto were included. A total of 349 lesions were included in this study, 50 (14%) of these were melanomas and no melanoma diagnosed had deep margin involvement, while 13 (26%) had lateral margin involvement.
Subject(s)
Melanoma/pathology , Melanoma/surgery , Nevus, Pigmented/surgery , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Adult , Aged , Biopsy , Dermatologic Surgical Procedures , Female , Humans , Male , Margins of Excision , Melanoma/diagnosis , Middle Aged , Neoplasm, Residual , Nevus, Pigmented/pathology , Prospective Studies , Reoperation , Skin/pathology , Skin Neoplasms/diagnosisABSTRACT
The emergence and dissemination of antibiotic resistant bacteria is a major medical challenge. Lantibiotics are highly modified bacterially produced antimicrobial peptides that have attracted considerable interest as alternatives or adjuncts to existing antibiotics. Nisin, the most widely studied and commercially exploited lantibiotic, exhibits high efficacy against many pathogens. However, some clinically relevant bacteria express highly specific membrane-associated nisin resistance proteins. One notable example is the nisin resistance protein that acts by cleaving the peptide bond between ring E and the adjacent serine 29, resulting in a truncated peptide with significantly less activity. We utilised a complete bank of bioengineered nisin (nisin A) producers in which the serine 29 residue has been replaced with every alternative amino acid. The nisin A S29P derivative was found to be as active as nisin A against a variety of bacterial targets but, crucially, exhibited a 20-fold increase in specific activity against a strain expressing the nisin resistance protein. Another derivative, nisin PV, exhibited similar properties but was much less prone to oxidation. This version of nisin with enhanced resistance to specific resistance mechanisms could prove useful in the fight against antibiotic resistant pathogens.
Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Bioengineering/methods , Nisin/chemistry , Nisin/pharmacology , Bacterial Proteins/metabolism , Drug Resistance, Bacterial , Food Preservatives/chemistry , Food Preservatives/pharmacology , Lipoproteins/metabolism , Membrane Proteins/metabolism , Microbial Sensitivity Tests , Nisin/geneticsABSTRACT
Establishing a diverse gut microbiota after birth is being increasingly recognised as important for preventing illnesses later in life. It is well established that bacterial diversity rapidly increases post-partum; however, few studies have examined the infant gut virome/phageome during this developmental period. We performed a metagenomic analysis of 20 infant faecal viromes at one year of age to determine whether spontaneous vaginal delivery (SVD) or caesarean section (CS) influenced viral composition. We find that birth mode results in distinctly different viral communities, with SVD infants having greater viral and bacteriophage diversity. We demonstrate that CrAssphage is acquired early in life, both in this cohort and two others, although no difference in birth mode is detected. A previous study has shown that bacterial OTU's (operational taxonomic units) identified in the same infants could not discriminate between birth mode at 12 months of age. Therefore, our results indicate that vertical transmission of viral communities from mother to child may play a role in shaping the early life microbiome, and that birth mode should be considered when studying the early life gut virome.
ABSTRACT
Fifteen Australian macrofungi were investigated for cytotoxic activity. Ethanol, cold and hot water extracts of each species were screened for cytotoxic activity against normal mouse fibroblast cells (NIH/3T3), healthy human epithelial kidney cells (HEK-293), four cancer cell lines, gastric adenocarcinoma cells (AGS), two mammary gland adenocarcinoma cells (MDA-MB-231, MCF7) and colorectal adenocarcinoma cells (HT-29) with a validated MTT assay. Most extracts derived from Omphalotus nidiformis, Cordyceps cranstounii and Cordyceps gunnii demonstrated significant cytotoxic activity toward a variety of cancer cell lines. In contrast only some extracts from Coprinus comatus, Cordyceps hawkesii, Hypholoma fasciculare, Lepista nuda, Leratiomyces ceres and Ophiocordyceps robertsii displayed significant cytotoxic activity, which was usually selective for only one or two cancer cell lines tested. The least cytotoxic species evaluated in this study were Agaricus bitorquis, Coprinopsis atrametaria, Psathyrella asperospora, Russula clelandii, Tricholoma sp. AU2 and Xerula mundroola.
Subject(s)
Antineoplastic Agents/pharmacology , Epithelial Cells/drug effects , Fungi/chemistry , Animals , Australia , Cell Line, Tumor , Dose-Response Relationship, Drug , Drug Discovery , Drug Screening Assays, Antitumor , HT29 Cells , Humans , Mice , NIH 3T3 CellsABSTRACT
In the advanced wound-care sector, there is an accelerating trend away from serial batch production towards transformational, continuous and integrated process lines. This is creating new standards and challenges in converting processes, which run faster, produce less waste and require fewer operators to run them. This article identifies those challenges and highlights the increasing importance of the relationship between wound-care manufacturer, materials science and the design of the converting process.
